ArticleMolecular and cellular biochemistry2026
Genetic and epidemiological insights into the role of neutrophil percentage in heart failure risk: a Mendelian randomization and NHANES study.
Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic inflammation contributes to the progression of heart failure (HF). However, the precise effects of platelet count (PCT), white blood cell count (WBC), neutrophil percentage (NEUT) on HF development and progression are poorly understood. Thus, in this study, we aimed to assess the associations between PCT, WBC, NEUT and HF. We utilized National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2018, excluding the second round of test data from 2001 to 2002, to assess HF using questionnaires and measured blood parameters adjusted by the covariates. We employed weighted quantile sum (WQS) regression to analyze the overall impact of multiple blood markers on HF, restricted cubic spline (RCS) analysis to assess non-linear relationships, and Mendelian randomization (MR) analysis using two-sample MR methods to examine genome-wide association study data. We also further confirmed the causal direction by Steiger test. The result from WQS regression showed that significant associations between PCT, WBC, and NEUT and HF. NEUT was most strongly linked to HF (P = 0.001), with heightened risk at levels ≥ 58.507%. RCS analysis showed a non-linear relationship of HF with WBC, where higher counts caused a shift from protective to increasing risk. MR analysis revealed a significant causal relationship between NEUT and HF (P = 0.00156), which was confirmed using the Steiger test. Reverse MR analysis indicated that HF had no significant impact on NEUT (P = 0.772). Our study highlights a significant correlation between NEUT and HF, indicating that NEUT might potentially serve as a biomarker for predicting HF.
Indexed as
Identifiers
41511722What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.